Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic -
Department of Rehabilitation and Sports Medicine, Second Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czech Republic.
Eur J Phys Rehabil Med. 2021 Oct;57(5):775-782. doi: 10.23736/S1973-9087.21.06682-X. Epub 2021 Mar 18.
Corticosteroid injections are proven to be effective in the management of carpal tunnel syndrome (CTS); however, the optimal injection site still remains unclear.
The aim of this study is to compare the efficacy of perineural vs. peritendinous target sites for corticosteroid injection in CTS.
A randomized, single-blind, controlled trial.
Outpatients, tertiary care center.
Forty-six patients were equally randomized into two intervention groups as group A (18 female and five male patients; mean age: 50.0±15.9 years; mean symptom duration: 5.9±3.3 months) and group B (19 female, four male patients; mean age: 54.3±15.0 years; mean symptom duration: 5.9±4.7 months).
Methylprednisolone acetate (40 mg) and 1 mL of 1% trimecaine hydrochloride was injected next to the median nerve (group A) or among flexor tendons away from the nerve (group B) under ultrasound (US) guidance. The visual analogue scale was used as the primary outcome measure, and the symptom severity scale and functional status scale of the Boston Carpal Tunnel Questionnaire were used as the secondary subjective outcome measures. Two-point discrimination, grip strength, cross-sectional area, and distal motor latency were assessed as objective outcome measures. The data were collected at baseline and at 2, 6 and 12 weeks after the injection.
Both groups showed improvement in subjective and objective measures at 2 weeks following the injection - also maintained up to 12 weeks during the follow-up (P<0.05). However, no difference was observed between the two groups (P<0.05). No serious adverse effects were observed in either group.
Both intervention techniques seem to be effective and safe in the conservative treatment of CTS.
Based on this study results, it might be noteworthy that physicians can opt for perineural or peritendinous injections without compromising the treatment efficacy and safety. Herewith, US guidance is, for sure, necessary for performing safe and accurate injections.
皮质类固醇注射已被证明在治疗腕管综合征(CTS)方面有效;然而,最佳注射部位仍不清楚。
本研究旨在比较神经周围与肌腱周围注射皮质类固醇治疗 CTS 的疗效。
随机、单盲、对照试验。
门诊,三级医疗中心。
46 名患者被平均随机分为两组:A 组(18 名女性和 5 名男性患者;平均年龄:50.0±15.9 岁;平均症状持续时间:5.9±3.3 个月)和 B 组(19 名女性,4 名男性患者;平均年龄:54.3±15.0 岁;平均症状持续时间:5.9±4.7 个月)。
在超声(US)引导下,甲泼尼龙醋酸酯(40mg)和 1ml 1%三甲卡因盐酸盐分别注射到正中神经旁(A 组)或肌腱间远离神经处(B 组)。视觉模拟量表是主要的观察指标,波士顿腕管问卷的症状严重程度量表和功能状态量表是次要的主观观察指标。两点辨别力、握力、横截面积和运动神经潜伏期作为客观观察指标进行评估。数据在基线和注射后 2、6 和 12 周收集。
两组患者在注射后 2 周内主观和客观测量均有改善,在随访期间(P<0.05)至 12 周时仍保持改善。然而,两组之间无差异(P<0.05)。两组均未观察到严重不良事件。
两种干预技术在 CTS 的保守治疗中似乎都是有效且安全的。
根据本研究结果,值得注意的是,医生可以选择神经周围或肌腱周围注射,而不会影响治疗效果和安全性。在此,超声引导对于进行安全、准确的注射是必要的。